Skip to main content

Table 2 Serotype distribution and antibiotic susceptibility according to initial blood culture results

From: Comparison of prognostic factors between bacteraemic and non-bacteraemic critically ill immunocompetent patients in community-acquired severe pneumococcal pneumonia: a STREPTOGENE sub-study

Variable

Positive blood culture (N = 212)

Negative blood culture (N = 127)

p value

Adjusted p valuea

Serotype, n (%)

< 0.0001

0.003

 3

45 (21.2)

36 (28.3)

  

 7F

38 (17.9)

14 (11.0)

  

 19A

31 (14.6)

18 (14.2)

  

 12F

19 (9.0)

3 (2.4)

  

 1

19 (9.0)

2 (1.6)

  

 6C

6 (2.8)

4 (3.1)

  

 11A

1 (0.5)

9 (7.1)

  

 Other

53 (25.0)

41 (32.3)

  

Serotype invasivenessb, n (%)

0.002

0.002

 High

166 (78.3)

78 (61.4)

  

 Low

13 (6.1)

20 (15.7)

  

 Undetermined

33 (15.6)

29 (22.8)

  

Serotype case fatality ratec, n (%)

< 0.0001

< 0.0001

 Low

72 (34.0)

19 (15.0)

  

 Intermediate

30 (14.2)

11 (8.7)

  

 High

102 (48.1)

86 (67.7)

  

 Other

8 (3.8)

11 (8.7)

  

Penicillin susceptible, n (%)

168 (79.2)

92 (72.4)

0.18

0.14

Amoxicillin susceptible, n (%)

198 (93.4)

107 (84.3)

0.009

0.010

Cefotaxime susceptible, n (%)

206 (97.2)

123 (96.9)

> 0.99

0.70

Erythromycin susceptible, n (%)

163 (76.9)

93 (73.2)

0.51

0.41

Levofloxacin susceptible, n (%)

210 (99.1)

127 (100.0)

0.53

  1. Data were available for 339 patients
  2. aAdjusted for age category, sex, BMI category, and McCabe and Charlson scores
  3. bSerotype invasiveness: high (OR > 1, p < 0.05), serotypes 1, 3, 4, 5, 7F, 12F, 14, 18C, 19A, and 9L; low (OR < 1, p < 0.05), serotypes 6A, 6C, 10A, 11A, 15A, 15C, 23B, 24F, and 37; and undetermined (OR < 1 or OR > 1 with p > 0.05), serotypes 8, 9A, 9N, 9V, 16F, 17F, 18A, 19F, 20, 22F, 23F, 29, 31, 33F, 34, 35B, and 35F
  4. cSerotype case fatality rate: low (serotypes 1, 4, 5, 7F, and 8), intermediate (serotypes 9V, 12F, 14, and 22F), or high (serotypes 3, 6A, 6B, 6C, 9N, 11A, 19A, 19F, and 23F)